Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients

Neuroscience Letters

Volumn 368, Issue 3, 2004, Pages 303-308

  Kolsch H ^a   Heun, R ^a   Kerksiek, A ^a   Bergmann, K V ^a   Maier, W ^a   Lutjohann D ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Brain; Cholesterol; Depression; Mild cognitive impairment; Vascular dementia

Indexed keywords

26 HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; ANALYSIS OF VARIANCE; DEMENTIA; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MIDDLE AGED;

EID: 4544282709     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.07.031     Document Type: Article

References (28)

1. A. Babiker, O. Andersson, D. Lindblom, L.J. van der Linden, B. Wiklund, D. Lütjohann, U. Diczfalusy, and I. Björkhem Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin J. Lipid Res. 40 1999 1417 1425
2. A. Babiker, and U. Diczfalusy Transport of side-chain oxidized oxysterols in the human circulation Biochim. Biophys. Acta Lipids Lipid Metab. 1392 1998 333 339
3. I. Björkhem, D. Lütjohann, O. Breuer, A. Sakinis, and A. Wennmalm Importance of a novel oxidative mechanism for elimination of brain cholesterol J. Biol. Chem. 48 1997 30178 30184
4. L. Bretillon, D. Lütjohann, L. Stahle, T. Widhe, L. Bindl, G. Eggertsen, U. Diczfalusy, and I. Björkhem Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J. Lipid Res. 41 2000 840 845
5. L. Bretillon, A. Siden, L.O. Wahlund, D. Lütjohann, L. Minthon, M. Crisby, J. Hillert, C.G. Groth, U. Diczfalusy, and I. Björkhem Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases Neurosci. Lett. 293 2000 87 90
6. J.J. Cali, C.L. Hsieh, U. Francke, and D.W. Russell Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis J. Biol. Chem. 266 1991 7779 7783
7. M. Del Puppo, M.G. Kienle, M.L. Petroni, A. Crosignani, and M. Podda Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway J. Lipid Res. 39 1998 2477 2482
8. S. Dzeletovic, O. Breuer, E. Lund, and U. Diczfalusy Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry Anal. Biochem. 225 1995 73 80
9. M.C. Englund, A.L. Karlsson, O. Wiklund, G. Bondjers, and B.G. Ohlsson 25-Hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-alpha secretion in macrophages Atherosclerosis 158 2001 61 71
10. C.G. Gottfries, W. Lehmann, and B. Regland Early diagnosis of cognitive impairment in the elderly with the focus on Alzheimer's disease J. Neural Transm. 105 1998 773 786
11. J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J. Lipid Res. 31 1990 545 548
12. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri, and D.A. Drachman Statins and the risk of dementia Lancet 356 2000 1627 1631
13. H. Jurevics, and P. Morell Cholesterol for synthesis of myelin is made locally, not imported into the brain J. Neurochem. 64 1995 895 901
14. H. Kölsch, D. Lütjohann, M. Ludwig, A. Schulte, U. Ptok, F. Jessen, K. von Bergmann, M.L. Rao, W. Maier, and R. Heun Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease Mol. Psychiatry 7 2002 899 902
15. J.M. Lehmann, S.A. Kliewer, L.B. Moore, T.A. Smith-Oliver, B.B. Oliver, J.-L. Su, S.S. Sundseth, D.A. Winegar, D.E. Blanchard, T.A. Spencer, and T.M. Willson Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway J. Biol. Chem. 272 1997 3137 3140
16. V. Leoni, T. Masterman, F.S. Mousavi, B. Wretlind, L.O. Wahlund, U. Diczfalusy, J. Hillert, and I. Björkhem Diagnostic use of cerebral and extracerebral oxysterols Clin. Chem Lab Med. 42 2004 186 191
17. V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Björkhem Side-chain oxidised oxysterols in cerebrospinal fluid and integrity of blood-brain and blood-CSF barriers J. Lipid Res. 44 2003 793 799
18. E.G. Lund, J.M. Guileyardo, and D.W. Russell cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain Proc. Natl. Acad. Sci. U.S.A. 96 1999 7238 7243
19. D. Lütjohann, O. Breuer, G. Ahlborg, I. Nennesmo, A. Sidén, U. Diczfalusy, and I. Björkhem Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation Proc. Natl. Acad. Sci. U.S.A. 93 1996 9799 9804
20. D. Lütjohann, A. Papassotiropoulos, I. Björkhem, A. Locatelli, M. Bagli, R.D. Oehring, U. Schlegel, F. Jessen, M.L. Rao, K. von Bergmann, and R. Heun Plasma 24S-hydroxy-cholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients J. Lipid Res. 41 1999 195 198
21. T.A. Miettinen, R.S. Tilvis, and Y.A. Kesaniemi Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population Am. J. Epidemiol. 131 1990 20 31
22. I.L. Notkola, R. Sulkava, J. Pekkanen, T. Erkinjuntti, C. Ehnholm, P. Kivinen, A. Tuomilehto, and A. Nissinen Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease Neuroepidemiology 17 1998 14 20
23. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch. Neurol. 56 1999 303 308
24. P. Schönknecht, D. Lütjohann, J. Pantel, H. Bardenheuer, T. Hartmann, K. von Bergmann, K. Beyreuther, and J. Schröder Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls Neurosci. Lett. 324 2002 83 85
25. M. Simons, P. Keller, B. De Strooper, K. Beyreuther, C.G. Dotti, and K. Simons Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons Proc. Natl. Acad. Sci. U.S.A. 95 1998 6460 6464
26. L.L. Smith, D.R. Ray, J.A. Moody, J.D. Wells, and J.E. Van Lier 24-hydroxycholesterol levels in human brain J. Neurochem. 19 1972 899 904
27. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90 1993 1977 1981
28. J.M. Upston, X. Niu, A.J. Brown, R. Mashima, H. Wang, R. Senthilmohan, A.J. Kettle, R.T. Dean, and R. Stocker Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis Am. J. Pathol. 160 2002 701 710